Grattagliano I - Search Results

1

Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.

Russmann S, Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Russmann S, et al. Among authors: grattagliano i. Curr Med Chem. 2006;13(27):3351-7. doi: 10.2174/092986706778773059. Curr Med Chem. 2006. PMID: 17168855 Review.

2

Re-wiring the circuit: mitochondria as a pharmacological target in liver disease.

Diogo CV, Grattagliano I, Oliveira PJ, Bonfrate L, Portincasa P. Diogo CV, et al. Among authors: grattagliano i. Curr Med Chem. 2011;18(35):5448-65. doi: 10.2174/092986711798194432. Curr Med Chem. 2011. PMID: 22087837 Review.

3

Current pharmacological treatment of nonalcoholic fatty liver.

Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Portincasa P, et al. Among authors: grattagliano i. Curr Med Chem. 2006;13(24):2889-900. doi: 10.2174/092986706778521878. Curr Med Chem. 2006. PMID: 17073635 Review.

4

Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.

Grattagliano I, Russmann S, Palmieri VO, Portincasa P, Palasciano G, Lauterburg BH. Grattagliano I, et al. Clin Pharmacol Ther. 2005 Oct;78(4):422-32. doi: 10.1016/j.clpt.2005.07.002. Clin Pharmacol Ther. 2005. PMID: 16198661

5

Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.

Grattagliano I, Russmann S, Palmieri VO, Jüni P, Bihl F, Portincasa P, Palasciano G, Lauterburg BH. Grattagliano I, et al. Hepatology. 2004 May;39(5):1248-55. doi: 10.1002/hep.20208. Hepatology. 2004. PMID: 15122753 Clinical Trial.

6

Current concepts of mechanisms in drug-induced hepatotoxicity.

Russmann S, Kullak-Ublick GA, Grattagliano I. Russmann S, et al. Among authors: grattagliano i. Curr Med Chem. 2009;16(23):3041-53. doi: 10.2174/092986709788803097. Curr Med Chem. 2009. PMID: 19689281 Free PMC article. Review.

7

Mitochondria in chronic liver disease.

Grattagliano I, Russmann S, Diogo C, Bonfrate L, Oliveira PJ, Wang DQ, Portincasa P. Grattagliano I, et al. Curr Drug Targets. 2011 Jun;12(6):879-93. doi: 10.2174/138945011795528877. Curr Drug Targets. 2011. PMID: 21269263 Review.

8

Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Grattagliano I, et al. J Nutr Biochem. 2008 Aug;19(8):491-504. doi: 10.1016/j.jnutbio.2007.06.011. Epub 2007 Sep 12. J Nutr Biochem. 2008. PMID: 17855068 Review.

9

Overview on the mechanisms of drug-induced liver cell death.

Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Grattagliano I, et al. Ann Hepatol. 2002 Oct-Dec;1(4):162-8. Ann Hepatol. 2002. PMID: 15280801 Review.

10

Esomeprazole-induced central fever with severe myalgia.

Grattagliano I, Portincasa P, Mastronardi M, Palmieri VO, Palasciano G. Grattagliano I, et al. Ann Pharmacother. 2005 Apr;39(4):757-60. doi: 10.1345/aph.1E377. Epub 2005 Mar 1. Ann Pharmacother. 2005. PMID: 15741426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results